51144-050Level 3
ADCETRIS (brentuximab vedotin)
**Product type:** Human Prescription Drug
**Active ingredient:** BRENTUXIMAB VEDOTIN
**Strength:** 50 mg/10.5mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** SEAGEN INC.
**Marketing category:** BLA (BLA125388)
**Pharmacologic class:** CD30-directed Antibody Interactions [MoA], CD30-directed Immunoconjugate [EPC], Immunoconjugates [CS], Microtubule Inhibition [PE]
GET
/api/v1/systems/ndc_fda/nodes/51144-050Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.